Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 701–800 of 1,001
Context Dependent Benzodiazepine Modulation of GABAA Receptor Opening Frequency
Bianchi, M. T. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909467 · Cited by 21
Lopes, D. V. S., Caruso, R. R. B., Castro, N. G., Costa, P. R. R., da Silva, A. J. M., & Noël, F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.026 · Cited by 21
Khom, S., Hintersteiner, J., Luger, D., Haider, M., Pototschnig, G., Mihovilovič, M. D., Schwarzer, C., & Hering, S. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232983 · Cited by 21
Sarantis, K., Sotiriou, E., Papatheodoropoulos, C., Matsokis, N. A., & Angelatou, F. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.016 · Cited by 21
Hwang, I. K., Park, S.-K., An, S.-J., Yoo, K., Kim, D., Jung, J., Won, M. H., Choi, S., Kwon, O., & Kang, T. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.026 · Cited by 21
Huang, X., Cao, H., Zhang, C., Lan, H., Gong, X., Li, R., Lin, Y., Xu, B., Chen, H., & Guan, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1143784 · Cited by 20
Auta, J., Kadriu, B., Giusti, P., Costa, E., & Guidotti, A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.016 · Cited by 20
Koester, C., Rudolph, U., Haenggi, T., Papilloud, A., Fritschy, J., & Crestani, F. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.004 · Cited by 20
Self-citationFerland, M. C., Therrien-Blanchet, J.-M., Proulx, S., Klees‐Themens, G., Bacon, B. A., Dang‐Vu, T. T., & Théoret, H. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.011 · Cited by 20
Ion Channel Blockers for the Treatment of Neuropathic Pain
Colombo, E. V., Francisconi, S., Faravelli, L., Izzo, E., & Pevarello, P. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.19 · Cited by 20
Fischer, B. D., Teixeira, L. P., Linn, M. L. V., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2975-2 · Cited by 20
Wasowski, C., Gavernet, L., Barrios, I. A., Villalba, M. L., Pastore, V., Samaja, G. A., Enrique, A., Bruno‐Blanch, L. E., & Marder, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.015 · Cited by 20
Alves, R., de Carvalho, J. G. B., & Venditti, M. A. C. (2012) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2012.23036 · Cited by 20
Auta, J., Gatta, E., Davis, J. M., Pandey, S. C., & Guidotti, A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.416 · Cited by 20
The interaction of sildenafil with the anticonvulsant effect of diazepam
Gholipour, T., Rasouli, A., Jabbarzadeh, A., Nezami, B. G., Riazi, K., Sharifzadeh, M. S., & Dehpour, A. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.061 · Cited by 20
Viola, H., Marder, M., Wasowski, C., Giorgi, O., Paladini, A. C., & Medina, J. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2979 · Cited by 20
Tanaka, M., Suemaru, K., Watanabe, S., Cui, R., Li, B., & Araki, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071991 · Cited by 20
Tan, K. R., Baur, R., Gonthier, A., Goeldner, M. P., & Sigel, E. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.068 · Cited by 20
Die Bedeutung von GABAA-Rezeptoren für Pathophysiologie und Therapie der Panikstörung
Rupprecht, R., & Zwanzger, P. (2003) · Der Nervenarzt · doi:10.1007/s00115-002-1433-x · Cited by 20
Imidazo[2,1-b]thiazepines: synthesis, structure and evaluation of benzodiazepine receptor binding
Kieć‐Kononowicz, K., Janina Karolak-wojciechowska, A., Michalak, B., Pękala, E., Schumacher, B., & Müller, C. E. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.11.009 · Cited by 20
Auta, J., Guidotti, A., & Costa, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.5.2314 · Cited by 20
Search for α3β2/3γ2 subtype selective ligands that are stable on human liver microsomes
Namjoshi, O. A., Wang, Z.-J., Rallapalli, S., Johnson, E. M., Johnson, Y.-T., Ng, H. H., Ramerstorfer, J., Varagić, Z., Sieghart, W., Majumder, S., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.057 · Cited by 19
Chagraoui, A., Skiba, M., Thuillez, C., & Thibaut, F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.08.001 · Cited by 19
Zhang, Y., Lian, Y., & Xie, N. (2017) · Medicine · doi:10.1097/md.0000000000009273 · Cited by 19
Herd, M. B., Lambert, J. J., & Belelli, D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12601 · Cited by 19
Schwienteck, K. L., Li, G., Poe, M. M., Cook, J. M., Banks, M. L., & Negus, S. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4615-8 · Cited by 19
Masneuf, S., Buetler, J., Koester, C., & Crestani, F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01763.x · Cited by 19
Self-citationReproductive experience reduces the sedative, but not anxiolytic effects of diazepam
Byrnes, E. M., & Bridges, R. S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.05.008 · Cited by 19
Filizola, M., Harris, D. L., & Loew, G. H. (2000) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2000.10506566 · Cited by 19
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology
Möhler, H. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.3/hmoehler · Cited by 19
Self-citation(2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80053-7 · Cited by 19
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
Berezhnoy, D., Gravielle, M. C., Downing, S., Kostakis, E., Basile, A. S., Skolnick, P., Gibbs, T. T., & Farb, D. H. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-11 · Cited by 18
Puig-Bosch, X., Bieletzki, S., Zeilhofer, H. U., Rudolph, U., Antkowiak, B., & Rammes, G. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004202 · Cited by 18
Self-citationGai, R. M., Back, D. F., & Zeni, G. R. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b01884 · Cited by 18
The effect of zolpidem on cognitive function and postural control at high altitude
Bouzat, P., Séchaud, G., Banco, P., Davranche, K., Casini, L. A., Baillieul, S., Manhes, P., Botrè, F., Mazzarino, M., de la Torre, X., et al. (2018) · SLEEP · doi:10.1093/sleep/zsy153 · Cited by 18
Cornett, E. M., Amarasinghe, S. N., Angelette, A. L., Abubakar, T., Kaye, A. M., Kaye, A. D., Neuchat, E. E., Urits, I., & Viswanath, O. (2021) · Neurology International · doi:10.3390/neurolint13010007 · Cited by 18
Gurrell, R., Iredale, P., Evrard, A., Duveau, V., Ruggiero, C., & Roucard, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13927 · Cited by 18
Developing dual functional allosteric modulators of GABAA receptors
Liu, X. F., Chang, H., Schmiesing, R. J., Wesolowski, S. S., Knappenberger, K. S., Arriza, J. L., & Chapdelaine, M. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.09.058 · Cited by 18
Morales, M., Varlinskaya, E. I., & SPEAR, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.004 · Cited by 18
Drexler, B., Zinser, S., Huang, S., Poe, M. M., Rudolph, U., Cook, J. M., & Antkowiak, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.034 · Cited by 18
Self-citationSkilbeck, K. J., Johnston, G. A. R., & Hinton, T. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.021 · Cited by 18
Hofmann, J. I., Schwarz, C., Rudolph, U., & Antkowiak, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143486 · Cited by 18
Self-citationFaulkner, M. A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s55930 · Cited by 18
Brown, L. E., Fuchs, C., Nicholson, M. W., Stephenson, F. A., Thomson, A. M., & Jovanovic, J. N. (2014) · Journal of Visualized Experiments · doi:10.3791/52115 · Cited by 18
Collins, I., Davey, W. B., Rowley, M., Quirk, K., Bromidge, F. A., McKernan, R. M., Thompson, S. A., & Wafford, K. A. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00245-6 · Cited by 18
Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients
Porter, B. E., Zhang, G., Celix, J. M., Hsu, F., Raol, Y. H., Telfeian, A. E., Gallagher, P. R., Coulter, D. A., & Brooks‐Kayal, A. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.010 · Cited by 18
The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone
Atack, J. R., Pike, A., Marshall, G. R., Stanley, J. L., Lincoln, R. J., Cook, S. M., Lewis, R. T., Blackaby, W., Goodacre, S. C., McKernan, R. M., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.014 · Cited by 18
Yoo, J. H., Ha, T.-W., Hong, J. T., & Oh, K. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.157 · Cited by 17
Mitrokhin, K. V., & Baranishin, A. A. (2018) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology201806122 · Cited by 17
Benoit, S., Chaumontet, C., Violle, N., Boulier, A., Hafeez, Z., Cakir‐Kiefer, C., Tomé, D., Schwarz, J., & Miclo, L. (2022) · Nutrients · doi:10.3390/nu14112212 · Cited by 17
Kawaharada, S., Nakanishi, M., Nakanishi, N., Hazama, K., Higashino, M., Yasuhiro, T., Lewis, A., Clark, G. S., Chambers, M. S., Maidment, S. A., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247627 · Cited by 17
Contribution of GABAA receptor subunits to attention and social behavior
Paine, T. A., Chang, S., & Poyle, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112261 · Cited by 17
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
Auvin, S. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1107 · Cited by 17
Jiménez-Velázquez, G., López‐Muñoz, F. J., & Fernández‐Guasti, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.021 · Cited by 17
Selective GABAA circuits for novel CNS drugs
Möhler, H., & Rudolph, U. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.019 · Cited by 17
Self-citationDai, S., Perouansky, M. A., & Pearce, R. A. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824be0e3 · Cited by 16
Kratovac, S., & Corbin, J. G. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.052 · Cited by 16
Facciolo, R. M., Madeo, M., Alò, R., Canonaco, M., & Dessì‐Fulgheri, F. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi322 · Cited by 16
Yuan, N. Y., Poe, M. M., Witzigmann, C., Cook, J. M., Stafford, D. C., & Arnold, L. A. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.08.006 · Cited by 16
Cook, J., Li, G., Golani, L. K., Jahan, R., & Rashid, F. (2018) · Synthesis · doi:10.1055/s-0037-1610211 · Cited by 16
Temporal Changes in Postural Sway Caused by Ultrashort-Acting Hypnotics: Triazolam and Zolpidem
Nakamura, M., Ishii, M., Niwa, Y., Yamazaki, M., & Ito, H. (2005) · ORL · doi:10.1159/000084998 · Cited by 16
TMD chronic pain and masseter silent period in psychiatric patients on antidepressive therapy
Ivković, N., Mladenović, I., PETKOVIC, S., & Stojić, D. L. (2008) · Journal of Oral Rehabilitation · doi:10.1111/j.0305-182x.2007.01819.x · Cited by 16
Zolpidem is a potent anticonvulsant in adult and aged mice
Vlainić, J., & Peričić, D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.018 · Cited by 16
Besson, M. J., Daali, Y., Lio, A. D., Dayer, P., Zeilhofer, H. U., & Desmeules, J. A. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12017 · Cited by 16
Indiplon in the management of insomnia
Lemon, M., Strain, J. D., Hegg, A. M., & Farver, D. (2009) · Drug Design Development and Therapy · doi:10.2147/dddt.s3207 · Cited by 16
Vinkers, C. H., van Oorschot, R., Korte, S. M., Olivier, B., & Groenink, L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1895-7 · Cited by 16
Basic Mechanisms of Psychotropic Drugs
Ebert, U. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.043s2002.x · Cited by 16
Caffeine Protects Against Anticonvulsant-Induced Neurotoxicity in the Developing Rat Brain
Endesfelder, S., Weichelt, U., Schiller, C., Sifringer, M., Bendix, I., & Bührer, C. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9768-z · Cited by 16
Neurobiological correlates of state-dependent context fear
Meyer, M. A. A., Corcoran, K. A., Chen, H. J., Gallego, S., Li, G., Tiruveedhula, V., Cook, J. M., & Radulović, J. (2017) · Learning & Memory · doi:10.1101/lm.045542.117 · Cited by 16
Mitchell, C. P., Grayson, D. R., & Goldman, M. B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.017 · Cited by 16
Morris, H. V., Nilsson, S. R. O., Dixon, C. I., Stephens, D. N., & Clifton, P. G. (2009) · Appetite · doi:10.1016/j.appet.2009.03.006 · Cited by 16
Carter, L. P., Griffiths, R. R., Suess, P. E., Casada, J. H., Wallace, C. L., & Roache, J. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119693 · Cited by 16
Possible Interaction of Zopiclone and Nefazodone
Alderman, C. P., Gebauer, M. G., Gilbert, A. L., & Condon, J. T. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a074 · Cited by 16
Kohut, S. J., & Ator, N. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.019 · Cited by 16
Designer genes and anti-anxiety drugs
Tecott, L. H. (2000) · Nature Neuroscience · doi:10.1038/75692 · Cited by 16
Agarwal, P., Misra, M., Sarkari, N. B. S., Gupta, A. K., & Agarwal, P. (1998) · PubMed · Cited by 16
Durkin, E., Muessig, L., Herlt, T., Lumb, M. J., Patel, R., Thomas, P., Bright, D. P., Jurd, R., Moss, S. J., Dickenson, A. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462457 · Cited by 16
Hsu, Y., Chang, Y., Chang, C., Siew, J. J., Chen, H., Tsai, C., & Chern, Y. (2017) · Movement Disorders · doi:10.1002/mds.27107 · Cited by 15
Bounthavong, M., Lau, M. K., Kay, C. L., Wells, D. L., Popish, S. J., Harvey, M. A., Himstreet, J. E., Grana, A., Freeman, B. A., Morillo, C. M., et al. (2020) · Pain Medicine · doi:10.1093/pm/pnaa475 · Cited by 15
Joksimovic, S. M., Divljaković, J., Linn, M. L. V., Varagić, Z., Brajković, G., Milinković, M. M., Yin, W., Stamenić, T. T., Sieghart, W., Cook, J. M., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.003 · Cited by 15
Gaurav, A., Yadav, M. R., Giridhar, R., Gautam, V., & Singh, R. (2010) · Medicinal Chemistry Research · doi:10.1007/s00044-010-9306-5 · Cited by 15
Analgesic effect of clobazam in chronic low‐back pain but not in experimentally induced pain
Schliessbach, J., Vuilleumier, P. H., Siegenthaler, A., Bütikofer, L., Limacher, A., Jüni, P., Zeilhofer, H. U., Arendt‐Nielsen, L., & Curatolo, M. (2017) · European Journal of Pain · doi:10.1002/ejp.1032 · Cited by 15
Li, G., Stephen, M. R., Kodali, R., Zahn, N. M., Poe, M. M., Tiruveedhula, V. V. N. P. B., Huber, A. T., Schussman, M. K., Qualmann, K. J., Panhans, C. M., et al. (2018) · ARKIVOC · doi:10.24820/ark.5550190.p010.460 · Cited by 15
Pflanz, N. C., Daszkowski, A. W., Cornelison, G. L., Trudell, J. R., & Mihic, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002128 · Cited by 15
Neumann, E., Küpfer, L., & Zeilhofer, H. U. (2020) · Pain · doi:10.1097/j.pain.0000000000002030 · Cited by 15
Beek, E. T. T., Chen, X., Jacobs, G. E., Nahon, K. J., de Kam, M. L., Lappalainen, J., Cross, A. J., van Gerven, J., & Hay, J. L. (2014) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.134 · Cited by 15
de Almeida, R. M. M., Benini, Q., Betat, J., Hipólide, D. C., Miczek, K. A., & Svensson, A. I. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1031-5 · Cited by 15
Shibasaki, M., Masukawa, D., Ishii, K., Yamagishi, Y., Mori, T., & Suzuki, T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12258 · Cited by 15
Dhanaraj, E., NEMMANI, K., & Ramarao, P. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.002 · Cited by 15
Behavioural characterization of four endemic Stachys taxa
Savić, M. M., Kukić‐Marković, J., Grayer, R. J., Milinković, M. M., Marin, P. D., Divljaković, J., Linn, M., Cook, J. M., & Petrović, S. (2010) · Phytotherapy Research · doi:10.1002/ptr.3106 · Cited by 15
Borsook, D., Pendse, G., Aiello‐Lammens, M., Glicksman, M. A., Gostic, J. M., Sherman, S. J., Korn, J., Shaw, M. E., Stewart, K., Gostic, R., et al. (2007) · Drug Development Research · doi:10.1002/ddr.20163 · Cited by 15
GABAA receptor modulators as anxioselective anxiolytics
Basile, A. S., LIPPA, A. S., & Skolnick, P. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.009 · Cited by 15
Synthesis and amphiphilic properties of glycosyl-1,4-benzodiazepin-2,5-diones
Bouhlal, D., Godé, P., Goethals, G., Massoui, M., Villa, P., & Martin, P. (2000) · Carbohydrate Research · doi:10.1016/s0008-6215(00)00163-4 · Cited by 15
Carling, R. W., Russell, M. G. N., Moore, K. W., Mitchinson, A., Guiblin, A. R., Smith, A. J., Wafford, K. A., Marshall, G. R., Atack, J. R., & Street, L. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.081 · Cited by 15
TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABAA receptors
Neumann, E., Ralvenius, W. T., Acuña, M. A., Rudolph, U., & Zeilhofer, H. U. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.026 · Cited by 14
Self-citationWagner, S., Lee, C., Rojas, L., Specht, C. G., Rhee, J., Brose, N., & Papadopoulos, T. G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100709 · Cited by 14
Pathogenic variants of human GABRA1 gene associated with epilepsy: A computational approach
Arslan, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20218 · Cited by 14
Limited central side effects of a β-subunit subtype-selective GABA A receptor allosteric modulator
Yoshimura, R. F., Tran, M. B., Hogenkamp, D. J., Johnstone, T. B. C., Xie, J. Y., Porreca, F., & Gee, K. W. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113507643 · Cited by 14
Hansen, R. R., Erichsen, H. K., Brown, D. T., Mirza, N. R., & Munro, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.002 · Cited by 14
Liljelund, P., Ferguson, C., Homanics, G. E., & Olsen, R. W. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.07.005 · Cited by 15
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.